{"DataElement":{"publicId":"65084","version":"3","preferredName":"Positive Malignant Neoplasm Specimen Percentage Value","preferredDefinition":"A measurement by percentage indicating the amount of malignant cells contained in a sample of tissue or body fluid.","longName":"PO_MALNE_SPE_PTG_VAL","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2010636","version":"3","preferredName":"Positive Malignant Neoplasm Specimen","preferredDefinition":"Information related to presence of malignant tumor or atypical neoplastic cells in a sample of tissue or body fluid removed for examination.","longName":"POS_MAL_NEOPL_SPEC","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206802","version":"1","preferredName":"Positive Malignant Neoplasm","preferredDefinition":"Involving advantage or good.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25246:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-051C-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2453802","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E070B71-8FA2-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-07","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-07","modifiedBy":"ONEDATA","dateModified":"2006-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0E070B71-8FA3-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-07","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-07","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/24/17 tt transferred context, added registration status and CSI per Round 5 finalization task. updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019134","version":"1","preferredName":"Malignant Neoplasm Specimen Percentage Value","preferredDefinition":"A percentage value expressing presence of malignant cells in a sample of tissue or body fluid.","longName":"MAL_NEO_SPEC_PTG_VAL","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C34B81CA-187E-66B7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-25","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/24/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811937","version":"1","longName":"Pathology Prostate","context":"CTEP"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812733","version":"1","longName":"FMISO Study","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3914494","version":"1","longName":"Diagnosis Microscopic Histology CRF","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5543567","version":"1","longName":"Reused-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5915898","version":"1","longName":"Microscopic Pathology","context":"NCI Standards"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"EDRN","type":"USED_BY","context":"EDRN"},{"name":"Reused-CDEs.Positive_Malignant_Neoplasm.SPECIMEN_TISSUE_PERCENTCA1SPECIMEN_VALUE_2210","type":"UML Qualified Attr","context":"EDRN"},{"name":"Positive_Malignant_Neoplasm:SPECIMEN_TISSUE_PERCENTCA1SPECIMEN_VALUE_2210","type":"UML Class:UML Attr","context":"EDRN"}],"ReferenceDocuments":[{"name":"Percent of cancer in specimen","type":"Preferred Question Text","description":"Percent of cancer in specimen","url":null,"context":"NCI Standards"},{"name":"COMMENT_520","type":"COMMENT","description":"Add instruction to form: %","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Specimen Cancer Present Percentage","url":null,"context":"CTEP"},{"name":"caBIG CRF","type":"Alternate Question Text","description":"Proportion Score (PS)","url":null,"context":"NCIP"},{"name":"Prior Question Text","type":"Alternate Question Text","description":"Percent of Cancer in Specimen\r\n","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0E6CDB93-F3FD-5386-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-07","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-07","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"8/24/17 tt transferred context, added registration status and CSI per Round 5 finalization task. updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}